Patient basic information Patient: Ms. Amira Moore) Nationality: Norway Disease diagnosis: Blue eye Diagnostic hospital: H0O treatment: Stem cell transplant + support treatment Household days: 171 days Treatment cost: about 286406 yuan Treatment effect: total relief The patient describes Ms. Amira from Norway who was diagnosed as blue eye locally.
Upon arrival, the International Medical Services team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, guidance and on-site services throughout the treatment process. The MD2 team used a comprehensive set of stem cell transplants + supportive treatments, during which the medical team closely monitored the patient's indicators, dynamic adjustment programs. After 171 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching the hospital standard.
The treatment effect was finally completely relaxed. When the patient was discharged, the medical team developed a detailed return follow-up and rehabilitation plan for him and continued to track the recovery through a remote follow-up system. The patient said 'We are impressed with the level of expertise of Chinese doctors and the condition of the equipment in Chinese hospitals, with a well laid out at every link from the ground to the hospital.
'Mrs. Liu Amira, experts have criticized this case as a typical case of cross-border suspected seriousness clinical cases. Liu4 is based on a multidisciplinary collaborative mechanism that developed a stem cell transplant + support treatment program for blue eyes, reflecting the comprehensive strength of Chinese hospitals in the field of suspected diagnostics and a summary of how international medical services are regulated.
(Figure from Liu5 official news reports and medical scenarios)